Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 401–500 of 1,011
Hostetler, H. A., Petrescu, A. D., Kier, A. B., & Schroeder, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412062200 · Cited by 169
Bayly, A. C., Roberts, R. A., & Dive, C. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.1.197 · Cited by 180
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Regulatory circuits controlling white versus brown adipocyte differentiation
Hansen, J. B., & Kristiansen, K. (2006) · Biochemical Journal · doi:10.1042/bj20060402 · Cited by 178
Role of PPARα in mediating the effects of phthalates and metabolites in the liver
Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., & Corton, J. C. (2005) · Toxicology · doi:10.1016/j.tox.2004.09.008 · Cited by 173
PPAR: a mediator of peroxisome proliferator action
Green, S. (1995) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(95)00136-0 · Cited by 176
Self-citationThe Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
Gurnell, M., Savage, D. B., Chatterjee, V. K. K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 179
Zhu, Y., Qi, C., Calandra, C., Rao, M. S. R., & Reddy, J. K. (1996) · Europe PMC (PubMed Central) · Cited by 215
Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation
Johnson, E. F., Palmer, C. N. A., Griffin, K. J., & Hsu, M. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836037 · Cited by 180
“BRL-49563 was shown to bind directly to PPARy (26); however, direct binding of peroxisome proliferators to PPARZ has not been demonstrated (7).”
BackgroundInfluentialObesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
Toyama, T., Nakamura, H., Harano, Y., Yamauchi, N., Morita, A., Kirishima, T., Minami, M., Itoh, Y., & Okanoue, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.110 · Cited by 172
Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
Nishimura, M., Naito, S., & Yokoi, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.135 · Cited by 173
The PPARα-Dependent Rodent Liver Tumor Response Is Not Relevant to Humans: Addressing Misconceptions
Corton, J. C., Peters, J. M., & Klaunig, J. E. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2094-7 · Cited by 175
“The seminal identification of a previously uncharacterized “orphan” nuclear receptor, the peroxisome proliferator-activated receptor α (PPARα), led to the discovery that many chemicals, despite their structural diversity, mediate at least some of their transcriptional effects through this receptor (Issemann and Green…”
BackgroundInfluentialRaney, A. K., Johnson, J. L., Palmer, C. N., & McLachlan, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1058-1071.1997 · Cited by 174
“unidentified endogenous ligand for this nuclear receptor (26).”
BackgroundEllinghaus, P., Wolfrum, C., Assmann, G., Spener, F., & Seedorf, U. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2766 · Cited by 170
Vohl, M.-C., Lepage, P., Gaudet, D., Brewer, C. G., Bétard, C., Perron, P., Houde, G., Cellier, C., Faith, J. M., Després, J.-P., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32037-x · Cited by 176
The Role of PPARαActivation in Liver and Muscle
Burri, L., Thoresen, G. H., & Berge, R. K. (2010) · PPAR Research · doi:10.1155/2010/542359 · Cited by 159
“Here we focus on the first identified PPAR receptor, PPARα [15], and its activation in different tissues and physiological states in humans and mice.”
BackgroundLong-chain polyunsaturated fatty acids: Selected mechanisms of action on bone
Kruger, M. C., Coetzee, M., Haag, M., & Weiler, H. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.06.002 · Cited by 167
Siddiqui, A. M., Cui, X., Wu, R., Dong, W., Zhou, M., Hu, M., Simms, H. H., & Wang, P. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000221921.71300.bf · Cited by 174
“The first PPAR was subsequently cloned from the mouse liver (12), followed by other PPAR homologs in Objective: Although phytochemical curcumin has been shown to possess anti-inflammatory properties, it remains unknown whether this agent has any beneficial effects in sepsis.”
BackgroundDiep, Q. N., Touyz, R. M., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.851 · Cited by 173
Is there a single mechanism for fatty acid regulation of gene transcription?
Duplus, E., & Forest, C. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01157-7 · Cited by 170
Guan, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139067.83419.46 · Cited by 175
“Naturally occurring PPAR- ligands including 15-deoxy- (12,14)prostaglandin J2 (22) and oxidized metabolites of linoleic acid 9-hydroxy- and 13-hydroxy-octadecadienoic acids have been identified (23,24).”
BackgroundGusdon, A. M., Song, K.-X., & Qu, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/637027 · Cited by 168
Dynamin‐related proteins and Pex11 proteins in peroxisome division and proliferation
Thoms, S., & Erdmann, R. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04939.x · Cited by 169
Jones, D. C., Ding, X., & Daynes, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106908200 · Cited by 169
Marcus, S. L., Miyata, K. S., Zhang, B., Subramani, S., Rachubinski, R. A., & Capone, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5723 · Cited by 171
Shen, P., Liu, M., Ng, T., Chan, Y., & Yong, E. L. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.4.899 · Cited by 170
Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
Suryadevara, V., Ramchandran, R., Kamp, D. W., & Natarajan, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124257 · Cited by 165
The role of fibric acids in atherosclerosis
Fruchart, J.-C., Staels, B., & Duriez, P. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0015-x · Cited by 170
Cytochrome P450 metabolizing fatty acids in plants: characterization and physiological roles
Pinot, F., & Beisson, F. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07948.x · Cited by 165
Proliferation and fission of peroxisomes — An update
Schrader, M., Costello, J. L., Godinho, L. F., Azadi, A. S., & Islinger, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.024 · Cited by 188
“These signalling pathways are usually initiated by external stimuli such as fatty acids or fibrates and lead to an increase in peroxisome number (usually termed “peroxisome proliferation”) [54,64].”
BackgroundGuengerich, F. P. (2010) · Comprehensive Toxicology · doi:10.1016/b978-0-08-046884-6.00404-8 · Cited by 170
Malapaka, R. R. V., Khoo, S., Zhang, J., Choi, J. H., Zhou, X. E., Xu, Y., Gong, Y., Li, J., Yong, E.-L., Chalmers, M. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294785 · Cited by 161
Varanasi, U., Chu, R., Huang, Q., Castellon, R., Yeldandi, A. V., & Reddy, J. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2147 · Cited by 169
Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training
Iemitsu, M., Miyauchi, T., Maeda, S., Tanabe, T., Takanashi, M., Irukayama-Tomobe, Y., Sakai, S., Ohmori, H., Matsuda, M., & Yamaguchi, I. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01051.2001 · Cited by 166
“PPAR- heterodimerizes with the retinoid X receptor (RXR- ) to bind to peroxisome proliferator-response elements (PPRE) in the upstream regions of a number of genes involved in metabolic homeostasis (13, 29).”
BackgroundInfluentialCLARKE, S. D., GASPERIKOVA, D., NELSON, C., LAPILLONNE, A., & HEIRD, W. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04284.x · Cited by 167
“DNA recognition site is markedly enhanced by ligands such as the hypotriglyceridemic fibrate drugs, conjugated linoleic acid, and HUFA (34-38).”
Qin, C., Burghardt, R. C., Smith, R., Wormke, M., Stewart, J., & Safe, S. H. (2003) · PubMed · Cited by 193
Ashby, J., & Paton, D. (1993) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(93)90003-x · Cited by 167
Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168
“The hepatic changes caused by treatment with peroxisome proliferators include liver hyperplasia and hypertrophy, proliferation of peroxisomes, and increases in the oxidation of fatty acids through induction of genes encoding mitochondrial, peroxisomal and microsomal enzymes involved in fatty acid oxidation [3,4].”
BackgroundPPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases
Lin, Y., Wang, Y., & Li, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074911 · Cited by 183
“As the first identified member of the family in 1990, PPARa was found activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes (3).”
BackgroundStimulation of PPARα Promotes Epidermal Keratinocyte Differentiation In Vivo
Kömüves, L. G., Hanley, K., Lefebvre, A.-M., Man, M.-Q., Ng, D. C., Bikle, D. D., Williams, M. L., Elias, P. M., Auwerx, J., & Feingold, K. R. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00073.x · Cited by 169
PPARγ in immunity and inflammation: cell types and diseases
Széles, L., Törőcsik, D., & Nagy, L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.005 · Cited by 196
Rivier, M., Safonova, I., Lebrun, P., Michel, S., Griffiths, C. E. M., & Ailhaud, G. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00439.x · Cited by 162
Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors
Falomir-Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 161
“These drugs were known as peroxisome proliferators, dubbing this receptor PPARs (Issemann and Green, 1990).”
BackgroundJiang, W. G., Douglas‐Jones, A., & Mansel, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11302 · Cited by 162
Heldin, C.-H., Lu, B., Evans, R., & Gutkind, J. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005900 · Cited by 146
“PPARa is highly expressed in the liver and is the target of the fibrate class of drugs used to control hyperlipidemia (Issemann and Green 1990).”
BackgroundPhenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome
Sybert, V. P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.217 · Cited by 164
Todisco, S., Santarsiero, A., Convertini, P., Stefano, G. D., Gilio, M., Iacobazzi, V., & Infantino, V. (2022) · Biology · doi:10.3390/biology11050792 · Cited by 181
“Among the peroxisome-proliferator-activated receptors, PPARα is the only member that is activated by peroxisome proliferators [26].”
BackgroundZambon, A., Gervois, P., Pauletto, P., Fruchart, J.-C., & Staels, B. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204327.96431.9a · Cited by 162
“Their effects impact on different steps of atherogenesis: (1) early markers of atherosclerosis, such as vascular wall reactivity, are improved; (2) however, reduced expression of adhesion molecules on the surface of endothelial cells, accompanied by decreased levels of inflammatory cytokines, such as TNF- , IL-1 and I…”
BackgroundCytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor α
Ng, V. Y., Huang, Y., Reddy, L. M., Falck, J. R., Lin, E. T., & Kroetz, D. L. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013839 · Cited by 158
“Peroxisome proliferators act via peroxisome proliferator-activated receptor (PPAR ) (Issemann and Green, 1990).”
BackgroundPhysiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Jamshidi, Y., Montgomery, H. E., Hense, H.-W., Myerson, S. G., Torra, I. P., Staels, B., World, M. J., Doering, A., Erdmann, J., Hengstenberg, C., et al. (2002) · Circulation · doi:10.1161/hc0802.104535 · Cited by 162
Finck, B. N., & Kelly, D. P. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2061 · Cited by 160
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Crossno, J. T., Garat, C. V., Reusch, J. E. B., Morris, K. G., Dempsey, E. C., McMurtry, I. F., Stenmark, K. R., & Klemm, D. J. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2006 · Cited by 158
“Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors including steroid, thyroid, and retinoid hormone receptors (36).”
BackgroundFat poetry: a kingdom for PPARγ
Anghel, S. I., & Wahli, W. (2007) · Cell Research · doi:10.1038/cr.2007.48 · Cited by 186
Faveeuw, C., Fougeray, S., Angeli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C., Capron, M., Staels, B., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02319-x · Cited by 158
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney
Yang, T., Michele, D. E., Park, J., Smart, A. M., Lin, Z., Brosius, F. C., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f966 · Cited by 162
Peroxisome proliferator-activated receptors: finding the orphan a home
Green, S., & Wahli, W. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90294-1 · Cited by 158
Self-citationAtherton, H. J., Bailey, N. J., Zhang, W., Taylor, J., Major, H., Shockcor, J., Clarke, K., & Griffin, J. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00060.2006 · Cited by 159
“The peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor transcription factors (20) involved in lipid metabolism regulation.”
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Youssef, J., & Badr, M. Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01383.x · Cited by 172
“Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that were discovered in 1990 (Issemann and Green, 1990) and are classified as members of the steroid hormone receptor superfamily.”
BackgroundChang, H. Y., Lee, H., Kim, W., & Surh, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.10.014 · Cited by 172
“DHA is a well-known ligand of PPARγ, which primarily controls glucose homeostasis, cell differentiation, lipid metabolism and inflammation [13,30].”
BackgroundYessoufou, A., & Wahli, W. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13071 · Cited by 154
NER, a new member of the gene family encoding the human steroid hormone nuclear receptor
SHINAR, D. M., Endo, N., Rutledge, S. J., Vogel, R., Rodan, G. A., & Schmidt, A. (1994) · Gene · doi:10.1016/0378-1119(94)90080-9 · Cited by 159
Fournier, T., Tsatsaris, V., Handschuh, K., & Evain‐Brion, D. (2006) · Placenta · doi:10.1016/j.placenta.2006.04.009 · Cited by 172
Dunning, K. R., Anastasi, M. R., Zhang, V. J., Russell, D. L., & Robker, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087327 · Cited by 177
“Overall, these results indicate that compared to PPARa, PPARc is a more active regulator of COC functions during oocyte maturation.”
BackgroundInfluentialKomar, C. M., Braissant, O., Wahli, W., & Curry, T. E. (2001) · Endocrinology · doi:10.1210/en.142.11.4831 · Cited by 155
Auwerx, J., Schoonjans, K., Fruchart, J.-C., & Staels, B. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05854-6 · Cited by 158
Burdick, A. D., Kim, D. J., Peraza, M. A., Gonzalez, F. J., & Peters, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.009 · Cited by 168
POIRIER, H., NIOT, I., MONNOT, M.-C., BRAISSANT, O., MEUNIER-DURMORT, C., COSTET, P., PINEAU, T., WAHLI, W., WILLSON, T. M., & BESNARD, P. (2001) · Biochemical Journal · doi:10.1042/bj3550481 · Cited by 149
Phytanic Acid is a Retinoid X Receptor Ligand
Lemotte, P. K., Keidel, S., & Apfel, C. M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00328.x · Cited by 152
PPAR Tissue Distribution and Interactions with Other Hormone‐Signaling Pathwaysa
Lemberger, T., Braissant, O., Juge-Aubry, C. E., KELLER, H., Saladin, R., Staels, B., Auwerx, J. H., Burger, A., Meier, C. A., & Wahli, W. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18619.x · Cited by 156
“1 pg/mL TPA, (4) 1 mM CAMP, (5) 600 )LM fenofibrate, (6) 4 mM butyrate, (7) 100 pM linoleic acid, (8) 0.”
Peroxisome proliferator activated receptors and obesity
Kersten, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01431-0 · Cited by 179
Lee, J., Jo, D., Park, D., Chung, H. Y., & Mattson, M. P. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007757 · Cited by 161
The Peroxisome Proliferator-activated Receptor α (PPARα) Regulates Bile Acid Biosynthesis
Hunt, M. C., Yang, Y.-Z., Eggertsen, G., Carneheim, C. M., Gåfvels, M., Einarsson, C., & Alexson, S. E. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002782200 · Cited by 155
Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs)
Sporn, M. B., Suh, N., & Mangelsdorf, D. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02100-1 · Cited by 159
Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction
Hu, Y., Chen, Y., Ding, L., He, X., Takahashi, Y., Gao, Y., Shen, W., Cheng, R., Chen, Q., Qi, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307211110 · Cited by 152
“Can J Physiol Pharmacol 86(7):465–471.”
BackgroundPPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed, W., Ziouzenkova, O., Brown, J., Devchand, P., Francis, S., Kadakia, M., Kanda, T., Orasanu, G., Sharlach, M., Zandbergen, F., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01825.x · Cited by 153
Khan, S. A., & Heuvel, J. P. V. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00098-6 · Cited by 180
The carcinogenicity of dichloroacetic acid in the male fischer 344 rat
DeAngelo, A. B., Daniel, F. B., Most, B. M., & Olson, G. R. (1996) · Toxicology · doi:10.1016/s0300-483x(96)03510-x · Cited by 153
Seimandi, M., Lemaire, G., Pillon, A., Perrin, A., Carlavan, I., Voegel, J. J., Vignon, F., Nicolas, J., & Balaguer, P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.06.010 · Cited by 153
The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain
Monaghan, A. P., Grau, E., Bock, D., & Schütz, G. (1995) · Development · doi:10.1242/dev.121.3.839 · Cited by 155
The peroxisome proliferator activated receptor regulates malic enzyme gene expression.
Castelein, H., Gulick, T., Declercq, P. E., Mannaerts, G. P., Moore, D. D., & Baes, M. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47083-4 · Cited by 154
Kallwitz, E. R., McLachlan, A., & Cotler, S. J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.22 · Cited by 150
PPAR expression and function during vertebrate development
Michalik, L., Desvergne, B., Dreyer, C., Gavillet, M., Laurini, R. N., & Wahli, W. (2002) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11902671 · Cited by 144
“…members of this superfamily, three different PPAR isotypes (PPARα, β/δ or FAAR or NUC1, and γ; NR1C1, NR1C2, NR1C3, respectively, Nuclear Receptor Nomenclature Commitee, 1999) have been identified in the early 1990’s in Xenopus laevis and the mouse (Dreyer et al., 1992; Issemann and Green, 1990).”
BackgroundIde, T., Kobayashi, H., Lakshmikuttyamma, A., Rouyer, I. A., Takahashi, Y., Aoyama, T., Hashimoto, T., & Mizugaki, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00026-3 · Cited by 165
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 177
4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent
Narender, T., Puri, A., ., S., Khaliq, T., Saxena, R., Bhatia, G., & Chandra, R. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.003 · Cited by 152
Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts
Chen, K., Chen, J., Li, D., Zhang, X., & Mehta, J. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000144400.49062.6b · Cited by 152
I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription
Clarke, S. D. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.4.g865 · Cited by 152
“In 1990, peroxisome proliferator-activated receptor (PPAR)-a, a novel lipidactivated transcription factor, was cloned (10).”
BackgroundPro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes Mellitus
Ringel, J., Engeli, S., Distler, A., & Sharma, A. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9962 · Cited by 163
PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue
Sun, C., Mao, S., Chen, S., Zhang, W., & Liu, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168974 · Cited by 156
“PPARα, the first rodent PPAR isoform to be identified and cloned, is expressed predominantly in the tissues that exhibit high capacity for fatty acid catabolism, such as kidneys, brown adipose tissue (BAT), liver, and skeletal muscle [6].”
BackgroundRuyter, B., Andersen, Ø., Dehli, A., Farrants, A. Ö., Gjøen, T., & Thomassen, M. S. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00080-5 · Cited by 173
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
Takada, I., & Makishima, M. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1703952 · Cited by 155
Gervois, P., Torra, I. P., Chinetti, G., Grötzinger, T., Dubois, G., Fruchart, J.-C., Fruchart-Najib, J., Leitersdorf, E., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0341 · Cited by 140
Staels, B., van Tol, A., Andreu, T., & Auwerx, J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.286 · Cited by 148
“-(32) Interestingly, a receptor activated by peroxisomal proliferators (such as fibrates) and belonging to the erb-A/steroid receptor gene superfamily has been recently cloned.(33) Receptors belonging to this family activate the transcription of ligand-inducible genes after binding as ligand-receptor complexes to spec…”
Liu, Q., Pan, R., Ding, L., Zhang, F., Hu, L., Ding, B., Zhu, L., Xia, Y., & Dou, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.026 · Cited by 149
Houck, K. A., Patlewicz, G., Richard, A. M., Williams, A. J., Shobair, M. A., Smeltz, M., Clifton, M. S., Wetmore, B., Medvedev, A., & Makarov, S. (2021) · Toxicology · doi:10.1016/j.tox.2021.152789 · Cited by 147
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
Kersten, S. (2008) · PPAR Research · doi:10.1155/2008/132960 · Cited by 149
“The seminal evidence that placed PPARα at the center of lipoprotein metabolism was the demonstration that fibrates, which had been used clinically for many years to treat dyslipidemia, act by binding to PPARα and induce PPARαdependent gene transcription [4, 14].”
Harano, Y., Yasui, K., Toyama, T., Nakajima, T., Mitsuyoshi, H., Mimani, M., Hirasawa, T., Itoh, Y., & Okanoue, T. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01265.x · Cited by 148
Peroxisome proliferation as a biomarker in environmental pollution assessment
Cajaraville, M. P., Cancio, I., Ibabe, A., & Orbea, A. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10329 · Cited by 148
“Enzyme induction occurs through transcriptional activation of the corresponding genes by peroxisome proliferator-activated receptors (PPARs), members of the nuclear receptor family (Issemann and Green, 1990).”
Background
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.